Karyopharm Therapeutics Inc.
KPTI
$8.38
-$0.17-1.99%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
Karyopharm Therapeutics (KPTI, $8.38) Stochastic Oscillator left the oversold zone on March 17, 2026
3/18/2026
-
Tickeron - Technical Analysis
3/17/2026
-
MarketBeat
3/14/2026
-
MarketBeat
3/9/2026
-
MarketBeat
3/7/2026
-
TipRanks Financial Blog
3/5/2026
-
Tickeron - Stocks
Karyopharm Therapeutics (KPTI, $9.14) Stochastic Oscillator left the oversold zone on March 04, 2026
3/5/2026
-
Tickeron - Stocks
3/4/2026
-
Tickeron - Stocks
3/2/2026
-
PR Newswire
2/28/2026
-
MarketBeat
2/28/2026
-
Ticker Report
2/27/2026
-
Tickeron - Stocks
2/26/2026
-
MarketBeat
2/24/2026
-
MarketBeat
2/20/2026
-
MarketBeat
2/18/2026
-
Zacks Investment Research
2/18/2026
-
MarketBeat
2/17/2026
-
Globe Newswire
2/16/2026
-
MarketBeat
2/14/2026
-
TipRanks Financial Blog
2/14/2026
-
TipRanks Financial Blog
2/13/2026
-
Simply Wall St
2/13/2026
-
Tickeron - Stocks
2/12/2026
-
Seeking Alpha: Transcripts
2/12/2026
-
SeekingAlpha
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, February 13, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 11 and 15 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
617 658 0600
Address
85 Wells Avenue
Newton, MA 02459-3298
Newton, MA 02459-3298
Country
Year Founded
Business Description
Sector
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other...
more